Skip to main navigation
  • Investors
  • News
  • Contact Us
Mimedx
  • Company
    About MIMEDX Management Team Board of Directors Committee Composition Code of Business Conduct and Ethics Quality Assurance & Regulatory
  • Products
    ADVANCED WOUND SOLUTIONS
    Epifix EpiCord
    ADVANCED SURGICAL SOLUTIONS
    AmnioFix AmnioCord AmnioBurn Product Catalog
  • Science
    The Healing Cascade SMR2T & Purion Medical Affairs Patents
  • Investors
  • News
  • Contact Us

News Releases

AddThis Sharing Buttons
Share to Facebook Facebook Share to Twitter Twitter Share to LinkedIn LinkedIn Share to Email Email

Investors Menu

  • Overview
  • Stock Information
  • SEC Filings
  • News Releases
  • Events & Presentations
  • Corporate Governance
  • Investor FAQs
  • Information Request

Investor Toolkit

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contact

News Releases

Keyword Search

Date Title
03/23/23
MIMEDX Announces Chief Financial Officer Transition
03/16/23
MIMEDX Comments on Recent Data Brief Published by Office of Inspector General
02/28/23
MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results
02/15/23
MIMEDX to Host Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call on February 28
01/30/23
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
01/09/23
MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates
01/04/23
MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED
01/03/23
MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer

Investors Menu

  • Overview
  • Stock Information
  • SEC Filings
  • News Releases
  • Events & Presentations
  • Corporate Governance
  • Investor FAQs
  • Information Request

Investor Toolkit

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contact

COMPANY

  • About MiMedx
  • Management Team
  • Board of Directors
  • Committee Composition
  • Code of Business Conduct and Ethics
  • Quality Assurance & Regulatory

PRODUCTS

  • EpiFix
  • EpiCord
  • AmnioFix
  • AmnioCord
  • Amnioburn
  • Product Catalog

SCIENCE

  • The Healing Cascade
  • SMR²T & Purion
  • Medical Affairs
  • Patents

RESOURCES

  • Investors
  • News
  • Archive
  • Returns

Contact Us

1775 West Oak Commons CT. NE
Marietta, GA 30062
Toll Free: 888.543.1917
Local: 770.651.9100
 

Contact Us

  • Contact Us
  • Terms of Use
  • Terms and Conditions
  • Purchase Order Terms and Conditions
  • Privacy Notice

MiMedx® is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues. This website is not meant as a substitute for professional medical advice.

© 2023 MiMedx. All rights reserved.